Word: criticalness
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...British film critic Anthony Lane once posed a rather devastating question. “What is the point of Demi Moore?” he asked. Now, after this year’s Oscar season has finally come to a close, Lane’s question deserves a broader application. Demi Moore aside, in a time when real, palpable problems shake our country, what is the point of Hollywood...
...Even those who are unhappy with Rivera's award seem to believe that Tomás and Camino have gone too far. Writing in El País, bullfighting critic Antonio Lorca said, "The decision of these two maestros isn't very elegant. This idea that 'the award was correct when they gave it to me, but not so much now' doesn't speak well of their sense of collegiality." Carlos Javier Trejo, a bullfighting critic based in Seville, agrees. "I think José Tomás had a little flare-up of vanity, like a Hollywood actor who returns...
...Taro Aso - the third lackluster holder of that office since Junichiro Koizumi resigned in 2006 - the dim view taken of his alleged role in the Nishimatsu scandal illuminates the paradox of Ozawa's place in Japanese politics. He is at one and the same time the single most radical critic of the Japanese postwar political establishment (it was his decision to bolt the LDP in 1993 that led to its only period out of office) and a supreme exemplar...
...medical schools are a new low. After the Times stories were published, Senator Charles Grassley, an Iowa Republican and longtime critic of drug-company influence, fired off a letter to Pfizer chairman and CEO Jeffrey Kindler describing himself as "greatly disturbed" by the reports and accusing Pfizer of trying to "intimidate young scholars." Grassley cited the 149 Harvard professors or instructors who have received payments or benefits from Pfizer specifically and demanded a detailed accounting of all of them. He closed with a terse "I look forward to hearing from you by no later than March 10, 2009." Pfizer...
...Harvard Medical School faculty on Tuesday, citing a recent New York Times report that 149 of the school’s faculty members have ties to the company. In a letter addressed to the Pfizer CEO, Grassley—a Republican from Iowa who has been an outspoken critic of conflicts of interest in medical research—gave the company until March 10 to produce a “detailed account” of payments to Medical School faculty since the beginning of 2007. Ray Kerins, a Pfizer spokesperson, told The Crimson yesterday that the company will give Grassley...